Wu H, Hernandez R, Crabb DP, Gazzard G, Harper RA, King A, Morgan JE, Takwoingi Y, Azuara-Blanco A, Watson V. Patient preferences for ocular hypertension monitoring: a discrete choice experiment. BMJ Open Ophthalmol. 2024 Oct 17;9(1):e001639. doi: 10.1136/bmjophth-2024-001639
Wu H, Gazzard G, King A, Morgan J, Wright D, Crabb DP, Takwoingi Y, Azuara-Blanco A, Watson V, Hernandez R. Cost-effectiveness of monitoring ocular hypertension based on a risk prediction tool. BMJ Open Ophthalmol. 2024 Aug 28;9(1):e001741. doi: 10.1136/bmjophth-2024-001741
Herring WL, Gould IG, Wittrup-Jensen V, Ertle J, Kuti E, Wolowacz S. Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes. J Comp Eff Res. 2022 Dec 1;11(18):1349-63. doi: 10.2217/cer-2021-0194
Joshi K, Muser E, Xu Y, Schwab P, Datar M, Suehs B. Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population. J Comp Eff Res. 2018 Aug;7(8):723-35. doi: 10.2217/cer-2018-0003
Meyers J, Gajria K, Candrilli SD, Fridman M, Sikirica V. The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder. J Comp Eff Res. 2017 Mar;6(2):109-25. doi: 10.2217/cer-2016-0039